Skip to main navigation
Skip to search
Skip to main content
Sort by
INIS
cancer
100%
prostate
69%
investigations
50%
inhibition
50%
pharmacology
46%
castration
46%
kinases
32%
phosphatases
31%
food
28%
processing
26%
herbs
25%
china
23%
medicine
23%
particles
23%
drug delivery
23%
carbon
23%
nanoparticles
23%
dna repair
23%
nanostructures
20%
humans
18%
drugs
14%
molecules
11%
apoptosis
9%
growth
9%
hydroxides
7%
cell proliferation
6%
therapy
5%
dna damages
5%
dna
5%
interactions
5%
Keyphrases
Crizotinib
46%
Prostate Radiotherapy
46%
Potential Therapeutics
46%
Cancer Stem-like
46%
Castration-resistant Prostate Cancer
46%
Intellectual Property
46%
Combinatorial Inhibition
46%
Beta-catenin
46%
Rhizoma Polygonati
23%
Network Pharmacology
23%
Anticancer Effect
23%
Combinatorial Drug
23%
Potent Drugs
23%
Herbal Diet
23%
Chemical Constituents
23%
Drug Delivery
23%
Mount Tai
17%
Mammalian Target of Rapamycin (mTOR)
17%
Faculty Development
11%
Grant Program
11%
Kinase Inhibitor
11%
Phosphatase
11%
Cell Growth
11%
Nutrition Source
5%
Extract Combination
5%
Nano Extract
5%
In Vitro Activity
5%
Epidermal Growth Factor Receptor Inhibitors (EGFRI)
5%
Phosphatase Activity
5%
Anticancer
5%
Enzymatic Mechanism
5%
High-speed Atomic Force Microscopy (HS-AFM)
5%
Anti-aging
5%
Anti-diabetes
5%
Target Network
5%
Optical Density Measurement
5%
Cell Proliferation Inhibition
5%
Component Network
5%
Anti-fatigue
5%
Processing Methods
5%
Dual Role
5%
Disease Prevention
5%
Long History
5%
Huangjing
5%
Chemical Target
5%
Pathway Targeting
5%
Experimental Validation
5%
Pharmacology, Toxicology and Pharmaceutical Science
Malignant Neoplasm
87%
Prostate Cancer
69%
Phosphatase
55%
Network Pharmacology
46%
Catenin
46%
Castration Resistant Prostate Cancer
46%
Phosphotransferase
34%
Crizotinib
30%
Nanozymes
26%
Carbon Nanoparticle
23%
Traditional Chinese Medicine
23%
Nicotinamide Adenine Dinucleotide Adenosine Diphosphate Ribosyltransferase Inhibitor
23%
Protein Kinase B
21%
Epidermal Growth Factor Receptor
18%
Phosphotransferase Inhibitor
15%
Hydroxyl Group
15%
Proteinase
7%
Atomic Force Microscopy
7%
Koji
7%
Diseases
7%
Enzyme
7%